Thompson CA, Yost K, Larson MC, et al. Changes in Quality of Life in Indolent Non-Hodgkin Lymphoma 3 Years after Diagnosis. ASH 59th Annual Meeting & Exhibition, abstract 917.
Rituximab-monotherapie versus afwachtend beleid bij gevorderd, asymptomatisch FL
aug 2025 | Lymfoom